X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.pharmatimes.com/news/nice_recommends_takedas_ninlaro_triplet_regimen_1485592
https://www.businesswire.com/news/home/20191107005221/en/Phase-3-Trial-NINLAROTM-ixazomib-Line-Maintenance/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.fiercepharma.com/pharma/takeda-scores-a-win-for-ninlaro-as-it-aims-to-pioneer-switch-maintenance-multiple-myeloma
https://www.fiercepharma.com/pharma/goodbye-deerfield-takeda-sets-december-deadline-for-reassignment-1-000-u-s-employees
https://www.fiercepharma.com/pharma/takeda-swings-and-misses-ninlaro-al-amyloidosis-calls-off-phase-3-trial
https://endpts.com/takeda-suffers-another-setback-in-its-quest-to-expand-myeloma-drugs-reach-and-blockbuster-potential/
https://www.fiercepharma.com/marketing/asco-j-j-eyes-darzalex-convenience-safety-boost-subcutaneous-win
https://www.ema.europa.eu/documents/product-information/ninlaro-epar-product-information_en.pdf
http://www.pmlive.com/pharma_news/takeda_cant_sway_nice_on_oral_myeloma_therapy_ninlaro_1204447
https://www.statnews.com/2017/06/23/china-death-penalty-research-fraud/
http://www.in-pharmatechnologist.com/Drug-Delivery/Takeda-breaks-ground-on-45m-Ninlaro-plant-in-Ireland
http://www.fiercepharma.com/marketing/takeda-sporting-a-new-look-cancer-portfolio-gears-up-for-roche-battle-alk
http://www.fiercepharma.com/pharma/takeda-shells-out-whopping-5-2b-for-ariad-iclusig-and-its-fledgling-med-brigatinib
https://www.pharmacompass.com/pdf/news/takeda-gets-eu-nod-forninlaro-ixazomib-citrate-1481198182.pdf
http://www.pharmatimes.com/news/conditional_eu_nod_for_takedas_ninlaro_1179504
http://www.fiercepharma.com/pharma/j-j-s-darzalex-jumps-into-second-line-race-new-fda-approval?
http://www.fiercepharma.com/pharma-asia/takeda-ceo-says-new-myeloma-drug-ninlaro-will-be-significantly-bigger-than-velcade
http://www.fiercepharma.com/pharma/reorg-new-meds-help-takeda-crawl-out-profit-hole
http://www.reuters.com/article/us-health-cancer-costs-idUSKCN0XX21H
Market Place
Share 
